Please login to the form below

Not currently logged in
Email:
Password:

EMA/HMA set drug application guidance

The European Medicines Agency and Heads of Medicines Agencies have released draft guidance detailing what information included in marketing authorisation applications for drugs can be released

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released draft guidance detailing what information included in marketing authorisation applications companies file for new drugs can be released.

The guidance defines what is commercially confidential information and personal data, with this information to remain protected.

The agencies said the measures are to make application dossiers 'more transparent' and to address requests from members of the public in a more efficient manner. Non-protected information is to become available once a marketing authoristation has been granted.

A consultation period for the draft measures is currently ongoing, with deadline for comments of September 1, 2011.

The EMA said: "The Agency and the HMA are particularly interested in receiving comments on the criteria for the release or protection of personal data, whether contractual arrangements between companies need to be maintained as confidential, and how to address the personal security of individuals involved in studies using animals."

Stakeholders are also invited to share ideas on how to make requests for information easier.

Following the consultation period, the EMA and the HMA will assess all comments received before completing a final version of the guidance document.

The EMA has the full draft guidance available for download.

Comments should be sent to hma-ematransparencyconsultation@ema.europa.eu

2nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics